PE20020189A1 - Oxazinquinolonas utiles en el tratamiento de infecciones virales - Google Patents
Oxazinquinolonas utiles en el tratamiento de infecciones viralesInfo
- Publication number
- PE20020189A1 PE20020189A1 PE2001000677A PE2001000677A PE20020189A1 PE 20020189 A1 PE20020189 A1 PE 20020189A1 PE 2001000677 A PE2001000677 A PE 2001000677A PE 2001000677 A PE2001000677 A PE 2001000677A PE 20020189 A1 PE20020189 A1 PE 20020189A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- het
- aryl
- oxazinquinolones
- useful
- Prior art date
Links
- 208000036142 Viral infection Diseases 0.000 title 1
- CIEWGZJDEDBECJ-UHFFFAOYSA-N 1-chloro-4-methylbenzene Chemical class [CH2]C1=CC=C(Cl)C=C1 CIEWGZJDEDBECJ-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 241000701022 Cytomegalovirus Species 0.000 abstract 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 abstract 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 abstract 1
- WZKSXHQDXQKIQJ-UHFFFAOYSA-N F[C](F)F Chemical class F[C](F)F WZKSXHQDXQKIQJ-UHFFFAOYSA-N 0.000 abstract 1
- 208000007514 Herpes zoster Diseases 0.000 abstract 1
- 241000701044 Human gammaherpesvirus 4 Species 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- YMNAJWHTELQUJU-UHFFFAOYSA-N quinoline-6-carboxamide Chemical compound N1=CC=CC2=CC(C(=O)N)=CC=C21 YMNAJWHTELQUJU-UHFFFAOYSA-N 0.000 abstract 1
- 241001529453 unidentified herpesvirus Species 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/20—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
SE REFIERE A DERIVADOS DE OXAZINQUINOLONAS Y TIOAZINQUINOLONAS CON UN ANILLO EN LA POSICION 4(N-4) CON LA POSICION 11(C-11) DE FORMULA I DONDE X ES O, S; Y ES Cl, F, Br, CN, NO2; R1, R2, R3, R4 SON H, N3, CN, F, TRIFLUOROMETILO, ARILO, ENTRE OTROS; R5 ES ALQUILO C1-C8 OPCIONALMENTE SUSTITUIDO CON N3, HALO, CN, R6, R7; R6 ES ARILO, HET, SOiR8, OR8, ENTRE OTROS; R7 ES PO(OR10)2, CO(CH2)CON(CH3)(CH2)kSO3(-)M(+), AMINOACIDO, ENTRE OTROS; R8 Y R9 SON H, CICLOALQUILO C3-C8, ARILO, HET, ENTRE OTROS; R10 ES H, ALQUILO C1-C8; R11 Y R12 SON H, HALO, NO2CN, ENTRE OTROS; ARILO ES FENILO FUSIONADO CON CARBOCICLO O HETEROCICLO; HET ES HETEROCICLO DE 4-7 MIEMBROS CON O, S, NW; W ES H, ALQUILO C1-C4, COO-ALQUILO C1-C4, ENTRE OTROS; i ES 0-2; j, k Y n SON 1-6; AL MENOS UNO DE R1, R2, R3, R4 ES DISTINTO DE H; CUANDO R1, R2, R3, R4 SON ALQUILO C1-C8, AL MENOS UNO DE LOS ALQUILO ESTA SUSTITUIDO CON R6, OR7; SON COMPUESTOS PREFERIDOS N-(4-CLOROBENCIL)-9-(MORFOLIN-4-ILMETIL)-7-OXO-2-(S)-PIRIDIN-2-IL-2,3-DIHIDRO-7H-[1,4]OXAZINO[2,3,4-ij]QUINOLIN-6-CARBOXAMIDA, N-(4-CLOROBENCIL)-2-(1-METIL-1H-IMIDAZOL-2-IL)-9-(MORFOLIN-4-ILMETIL)-7-OXO-2,3-DIHIDRO-7H-[1,4]OXAZINO[2,3,4-ij]QUINOLIN-6-CARBOXAMIDA, ENTRE OTROS. LOS COMPUESTOS SON INHIBIDORES DE DNA POLIMERASA VIRAL Y PUEDEN SER UTILES PARA PREVENIR INFECCIONES POR HERPESVIRUS, VARICELA ZOSTER, CITOMEGALOVIRUS, VIRUS DE EPSTEIN BARR
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21755500P | 2000-07-12 | 2000-07-12 | |
| US26221101P | 2001-01-17 | 2001-01-17 | |
| US26825501P | 2001-02-13 | 2001-02-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20020189A1 true PE20020189A1 (es) | 2002-03-02 |
Family
ID=27396428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2001000677A PE20020189A1 (es) | 2000-07-12 | 2001-07-09 | Oxazinquinolonas utiles en el tratamiento de infecciones virales |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1299395B1 (es) |
| JP (1) | JP2004502777A (es) |
| AR (1) | AR030304A1 (es) |
| AT (1) | ATE276262T1 (es) |
| AU (1) | AU2001269704A1 (es) |
| DE (1) | DE60105614T2 (es) |
| ES (1) | ES2227232T3 (es) |
| PE (1) | PE20020189A1 (es) |
| PT (1) | PT1299395E (es) |
| TR (1) | TR200402534T4 (es) |
| WO (1) | WO2002004462A1 (es) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6821969B2 (en) | 2001-02-13 | 2004-11-23 | Pharmacia & Upjohn Company | Thioxazinoquinolones as antiviral agents |
| MXPA05010776A (es) * | 2003-04-07 | 2006-05-25 | Cylene Pharmaceuticals Inc | Analogos sustituidos de quinobenzoxazina. |
| MX2008011633A (es) | 2006-03-13 | 2008-12-16 | Activx Biosciences Inc | Aminoquinolonas como inhibidores de gsk-3. |
| US8389514B2 (en) | 2007-09-11 | 2013-03-05 | Kyorin Pharmaceutical Co., Ltd. | Cyanoaminoquinolones and tetrazoloaminoquinolones as GSK-3 inhibitors |
| JP5373799B2 (ja) | 2007-09-12 | 2013-12-18 | 杏林製薬株式会社 | Ｇｓｋ−３阻害剤としてのスピロ環式アミノキノロン |
| US8071591B2 (en) | 2009-03-11 | 2011-12-06 | Kyorin Pharmaceutical Co., Ltd. | 7-cycloalkylaminoquinolones as GSK-3 inhibitors |
| SG11201502369XA (en) | 2012-10-16 | 2015-05-28 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of ror-gamma-t |
| WO2014062655A1 (en) | 2012-10-16 | 2014-04-24 | Janssen Pharmaceutica Nv | HETEROARYL LINKED QUINOLINYL MODULATORS OF RORyt |
| ES2628365T3 (es) | 2012-10-16 | 2017-08-02 | Janssen Pharmaceutica N.V. | Moduladores de quinolinilo unidos a fenilo de ROR-GAMA-T |
| US10555941B2 (en) | 2013-10-15 | 2020-02-11 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of RORγt |
| US9284308B2 (en) | 2013-10-15 | 2016-03-15 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of RORγt |
| KR20160068956A (ko) | 2013-10-15 | 2016-06-15 | 얀센 파마슈티카 엔.브이. | RORyT의 퀴놀리닐 조절제 |
| US9221804B2 (en) | 2013-10-15 | 2015-12-29 | Janssen Pharmaceutica Nv | Secondary alcohol quinolinyl modulators of RORγt |
| US9328095B2 (en) | 2013-10-15 | 2016-05-03 | Janssen Pharmaceutica Nv | Heteroaryl linked quinolinyl modulators of RORgammat |
| KR20160070133A (ko) | 2013-10-15 | 2016-06-17 | 얀센 파마슈티카 엔.브이. | RORyt의 알킬 결합 퀴놀리닐 조절제 |
| US9403816B2 (en) | 2013-10-15 | 2016-08-02 | Janssen Pharmaceutica Nv | Phenyl linked quinolinyl modulators of RORγt |
| US11072610B2 (en) | 2018-09-12 | 2021-07-27 | Novartis Ag | Antiviral pyridopyrazinedione compounds |
| CN120842223A (zh) | 2019-09-26 | 2025-10-28 | 诺华股份有限公司 | 抗病毒吡唑并吡啶酮化合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4959363A (en) * | 1989-06-23 | 1990-09-25 | Sterling Drug Inc. | Quinolonecarboxamide compounds, their preparation and use as antivirals. |
| US5792774A (en) * | 1996-02-21 | 1998-08-11 | Chiroscience Limited | Quinolones and their therapeutic use |
| WO1999040093A2 (en) * | 1998-02-04 | 1999-08-12 | Board Of Regents, The University Of Texas System | Synthesis of quinobenzoxazine analogues with topoisomerase ii and quadruplex interactions for use as antineoplastic agents |
| US6248739B1 (en) * | 1999-01-08 | 2001-06-19 | Pharmacia & Upjohn Company | Quinolinecarboxamides as antiviral agents |
| TW500724B (en) * | 1999-10-05 | 2002-09-01 | Pharmacia & Amp Upjohn Company | Oxazinoquinolones useful for the treatment of viral infections |
-
2001
- 2001-06-29 TR TR2004/02534T patent/TR200402534T4/xx unknown
- 2001-06-29 JP JP2002509326A patent/JP2004502777A/ja active Pending
- 2001-06-29 PT PT01948231T patent/PT1299395E/pt unknown
- 2001-06-29 ES ES01948231T patent/ES2227232T3/es not_active Expired - Lifetime
- 2001-06-29 DE DE60105614T patent/DE60105614T2/de not_active Expired - Fee Related
- 2001-06-29 WO PCT/US2001/016507 patent/WO2002004462A1/en not_active Ceased
- 2001-06-29 AU AU2001269704A patent/AU2001269704A1/en not_active Abandoned
- 2001-06-29 EP EP01948231A patent/EP1299395B1/en not_active Expired - Lifetime
- 2001-06-29 AT AT01948231T patent/ATE276262T1/de not_active IP Right Cessation
- 2001-07-09 PE PE2001000677A patent/PE20020189A1/es not_active Application Discontinuation
- 2001-07-12 AR ARP010103311A patent/AR030304A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1299395E (pt) | 2005-01-31 |
| ES2227232T3 (es) | 2005-04-01 |
| TR200402534T4 (tr) | 2004-12-21 |
| DE60105614T2 (de) | 2005-10-06 |
| JP2004502777A (ja) | 2004-01-29 |
| EP1299395B1 (en) | 2004-09-15 |
| DE60105614D1 (de) | 2004-10-21 |
| ATE276262T1 (de) | 2004-10-15 |
| AR030304A1 (es) | 2003-08-20 |
| AU2001269704A1 (en) | 2002-01-21 |
| EP1299395A1 (en) | 2003-04-09 |
| WO2002004462A1 (en) | 2002-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20020189A1 (es) | Oxazinquinolonas utiles en el tratamiento de infecciones virales | |
| PE20020143A1 (es) | Carboxamidas heterociclicas como agentes antivirales | |
| PE20020823A1 (es) | Derivados de nucleosidos como inhibidores de polimerasa de arn viral dependiente de arn | |
| PE20010736A1 (es) | PIRAZOL-[4,3-d]-PIRIMIDIN-7-ONA COMO INHIBIDORES DE LA 3`,5'-GUANOSINMONOFOSFATO CICLICO FOSFODIESTERASA | |
| TNSN01011A1 (en) | 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS | |
| EA200000969A1 (ru) | ИНГИБИТОРЫ цГМБ ФДЭ5 НА ОСНОВЕ ПИРАЗОЛПИРИМИДИНОНА ДЛЯ ЛЕЧЕНИЯ ПОЛОВЫХ ДИСФУНКЦИЙ | |
| PE20040168A1 (es) | Compuestos de pirrolopiridazina como inhibidores de las proteina cinasas | |
| AR032637A1 (es) | Compuestos de pirrolotriazina, utiles como inhibidores de la actividad de la cinasa p38 y las composiciones farmaceuticas que los contienen | |
| AR038341A1 (es) | Compuestos que son agonistas de receptores alfa-1 preferentemente agonistas de receptores alfa-1a/l | |
| AR035548A1 (es) | Compuestos organicos | |
| EA200400886A1 (ru) | Макроциклические пептиды, обладающие активностью в отношении вируса гепатита c | |
| PE20070189A1 (es) | COMPUESTO DE AMINO-5-HETEROARILO (5 MIEMBROS) IMIDAZOLONA Y SU USO PARA MODULACION DE LA ß-SECRETASA | |
| AR036095A1 (es) | Compuestos de pirazina que actuan como ligandos del receptor de 5-ht | |
| AR072047A1 (es) | Compuestos heterociclicos utiles para inhibir la adn girasa | |
| PE20020974A1 (es) | Quinolincarboxamidas sustituidas como agentes antivirales | |
| ATE362912T1 (de) | Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha | |
| DK0701553T3 (da) | Svampedræbende arylpyrazoler | |
| PE20030430A1 (es) | 6,7-DIHIDRO-5H-PIRAZOLO[1,2-a]PIRAZOL-1-ONAS QUE CONTROLAN CITOQUINAS INFLAMATORIAS | |
| ATE251117T1 (de) | Neue aminobenzophenone | |
| PE20010598A1 (es) | Oxazinquinolonas utiles en el tratamiento de infecciones virales | |
| CO5261560A1 (es) | Nuevos derivados de tiazolidindiona como agentes antidiabeticos | |
| AR016501A1 (es) | Compuestos inhibidores de las fkbp, composiciones farmaceuticas, uso para la preparacion de medicamentos y procesos de preparacion e intermediarios. | |
| NO165802C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazopyridiner. | |
| BG103554A (en) | Substituted pyrazol-3-ylbenzazoles | |
| AR045600A1 (es) | Tienoimidazoles sustituidos, procedimiento para su preparacion, su uso como un medicamento o adyuvante de diagnostico y medicamento que los comprende |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |